Pascal George

2.6k total citations
64 papers, 1.5k citations indexed

About

Pascal George is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Pascal George has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 26 papers in Organic Chemistry and 18 papers in Cellular and Molecular Neuroscience. Recurrent topics in Pascal George's work include Neuroscience and Neuropharmacology Research (11 papers), Glycosylation and Glycoproteins Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Pascal George is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Glycosylation and Glycoproteins Research (10 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). Pascal George collaborates with scholars based in France, United States and Germany. Pascal George's co-authors include Mireille Sevrin, H. Depoortere, Salomón Z. Langer, S. Arbilla, Pierre Louisot, Samir Jegham, Gino Ricci, Pierre Broquet, Michel Bottlaender and Vincent Gandon and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Pascal George

64 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pascal George France	22	645	569	487	144	122	64	1.5k
Shil Patel United States	29	1.3k 2.0×	471 0.8×	1.1k 2.3×	102 0.7×	150 1.2×	59	2.4k
Michael A. Letavic United States	31	672 1.0×	662 1.2×	184 0.4×	182 1.3×	152 1.2×	69	2.3k
J.S. Dileep Kumar United States	26	586 0.9×	648 1.1×	570 1.2×	156 1.1×	348 2.9×	99	2.0k
Janusz J. Kulagowski United Kingdom	29	1.2k 1.8×	806 1.4×	1.1k 2.3×	119 0.8×	160 1.3×	55	2.3k
Christophe Plisson United Kingdom	22	558 0.9×	255 0.4×	437 0.9×	140 1.0×	168 1.4×	57	1.4k
Sarah Grimwood United States	28	1.1k 1.7×	401 0.7×	1.0k 2.1×	123 0.9×	194 1.6×	52	2.0k
James C. Barrow United States	29	1.2k 1.8×	823 1.4×	429 0.9×	133 0.9×	302 2.5×	68	2.4k
Kathryn A. Lyons United States	24	514 0.8×	416 0.7×	409 0.8×	100 0.7×	98 0.8×	45	1.6k
Jaya Prabhakaran United States	20	426 0.7×	492 0.9×	376 0.8×	68 0.5×	227 1.9×	75	1.3k
Sylvie Mavel France	26	744 1.2×	480 0.8×	201 0.4×	206 1.4×	108 0.9×	63	1.7k

Countries citing papers authored by Pascal George

Since Specialization

Citations

This map shows the geographic impact of Pascal George's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal George with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal George more than expected).

Fields of papers citing papers by Pascal George

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal George. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal George. The network helps show where Pascal George may publish in the future.

Co-authorship network of co-authors of Pascal George

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal George. A scholar is included among the top collaborators of Pascal George based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal George. Pascal George is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hurst, W. Jeffrey, Werngard Czechtizky, Dominique Françon, et al.. (2013). Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep–wake disorders. Bioorganic & Medicinal Chemistry Letters. 23(22). 6141–6145. 5 indexed citations

Hurst, W. Jeffrey, et al.. (2013). Synthesis, characterization, and biological assessment of the four stereoisomers of the H3 receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3′]bipyrrolidinyl-1′-yl)phenyl]benzamide. Bioorganic & Medicinal Chemistry Letters. 23(14). 4044–4047. 4 indexed citations

Hurst, W. Jeffrey, et al.. (2013). Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression. Bioorganic & Medicinal Chemistry Letters. 23(23). 6269–6273. 19 indexed citations

George, Pascal, et al.. (2011). Synthesis and biological evaluation of analogues of M6G. European Journal of Medicinal Chemistry. 46(9). 4035–4041. 13 indexed citations

Saba, Wadad, Héric Valette, Marie‐Anne Peyronneau, et al.. (2009). [¹¹C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: Preclinical characterisation in nonhuman primate. Synapse. 64(1). 61–69. 47 indexed citations

Claustre, Y., Philippe Brun, Christiane Gueudet, et al.. (2003). SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological Profile. Neuropsychopharmacology. 28(12). 2064–2076. 41 indexed citations

Bottlaender, Michel, Frédéric Dollé, Ilonka Guenther, et al.. (2003). Mapping the Cerebral Monoamine Oxidase Type A: Positron Emission Tomography Characterization of the Reversible Selective Inhibitor [11C]Befloxatone. Journal of Pharmacology and Experimental Therapeutics. 305(2). 467–473. 23 indexed citations

Griebel, Guy, Ghislaine Perrault, Jacques Simiand, et al.. (2003). SL651498, a GABA_AReceptor Agonist with Subtype‐Selective Efficacy, as a Potential Treatment for Generalized Anxiety Disorder and Muscle Spasms. CNS Drug Reviews. 9(1). 3–20. 66 indexed citations

Dollé, Frédéric, Héric Valette, Yann Bramoullé, et al.. (2003). Synthesis and in vivo imaging properties of [11C]befloxatone: A novel highly potent positron emission tomography ligand for mono-amine oxidase-A. Bioorganic & Medicinal Chemistry Letters. 13(10). 1771–1775. 35 indexed citations

10.

George, Pascal, et al.. (2001). Dietary Spermidine and Spermine Participate in the Maturation of Galactosyltransferase Activity and Glycoprotein Galactosylation in Rat Small Intestine. Journal of Nutrition. 131(7). 1890–1897. 23 indexed citations

11.

Dekhane, Mouloud, Mireille Le Hyaric, Hans E. Schoemaker, et al.. (1999). Synthesis and benzodiazepine receptor (ω receptor) affinities of 3-substituted derivatives of pyrrolo[2,3-c]pyridine-5-carboxylate, a novel class of ω1 selective ligands1This article is dedicated to the memory of our friend and colleague, Sir Derek Barton.1. Bioorganic & Medicinal Chemistry. 7(5). 921–932. 9 indexed citations

12.

George, Pascal, et al.. (1999). Spermidine-induced glycoprotein fucosylation in immature rat intestine. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 322(7). 543–549. 2 indexed citations

13.

Ooms, Frédéric, Johan Wouters, Sonia Collin, et al.. (1998). Molecular lipophilicity potential by clip, a reliable tool for the description of the 3D distribution of lipophilicity: Application to 3-phenyloxazolidin-2-one, a prototype series of reversible MAOA inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(11). 1425–1430. 8 indexed citations

14.

Reboul, Pascal, et al.. (1996). Study ofO-sialylation of glycoproteins in C6 glioma cells treated with retinoic acid. Glycoconjugate Journal. 13(1). 69–79. 3 indexed citations

15.

Reboul, Pascal, et al.. (1992). Study of o-glycan sialylation in c6 cultured glioma cells: Regulation of a β-galactoside α2,3 sialyltransferase activity by ca2+/calmodulin antagonists and phosphatase inhibitors. Biochemical and Biophysical Research Communications. 186(3). 1575–1581. 7 indexed citations

16.

Broquet, Pierre, et al.. (1991). Study of O-glycan sialylation in C6 cultured glioma cells: Evidence for post-translational regulation of Aβ-galactoside α2,3 sialyltransferase activity by N-glycosylation. Biochemical and Biophysical Research Communications. 178(3). 1437–1443. 9 indexed citations

17.

Broquet, Pierre, et al.. (1990). Effect of Desipramine on a Glycoprotein Sialyltransferase Activity in C6 Cultured Glioma Cells. Journal of Neurochemistry. 54(2). 388–394. 7 indexed citations

18.

Reboul, Pascal, Pierre Broquet, Pascal George, & Pierre Louisot. (1990). Effect of retinoic acid on two glycosyltransferase activities in c6 cultured glioma cells. International Journal of Biochemistry. 22(8). 889–893. 11 indexed citations

19.

Broquet, Pierre, et al.. (1989). Different reactivity of two Brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc?2-3Gal?1-3GalNAc ?(2?6)sialyltransferase. Glycoconjugate Journal. 6(1). 115–127. 11 indexed citations

20.

Broquet, Pierre, et al.. (1989). Evidence for an O‐glycan sialylation system in brain. European Journal of Biochemistry. 182(2). 257–265. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact